The TAKE method based on CRISPR/Cas9 technology generated a G to A change resulting in a glycine to serine substitution at amino acid 25 (p.G25S). (J:305716)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count